[1]
L. D. Mocan Hognogi and L. V. Simiti, “THE CARDIOVASCULAR IMPACT OF VISFATIN - AN INFLAMMATION PREDICTOR BIOMARKER IN METABOLIC SYNDROME”, Med Pharm Rep, vol. 89, no. 3, pp. 322–326, Jul. 2016.